Page last updated: 2024-10-31

metoclopramide and Uterine Neoplasms

metoclopramide has been researched along with Uterine Neoplasms in 6 studies

Metoclopramide: A dopamine D2 antagonist that is used as an antiemetic.
metoclopramide : A member of the class of benzamides resulting from the formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with the primary amino group of N,N-diethylethane-1,2-diamine.

Uterine Neoplasms: Tumors or cancer of the UTERUS.

Research Excerpts

ExcerptRelevanceReference
"Metoclopramide was given at a dosage of 2 mg/kg (H) or 1 mg/kg (M), intravenously, 30 minutes before and 2."6.66[Randomized controlled study of high-dose metoclopramide (2 mg/kg x 4:H) vs moderate-dose metoclopramide (1 mg/kg x 4:M) in the prevention of CDDP-induced emesis]. ( Dozono, H; Ohmi, K, 1986)
"and metoclopramide 0."5.29Treatment of cisplatin-related nausea and vomiting with a combination of ondansetron and metoclopramide: a pilot study. ( Cannata, G; Gebbia, N; Gebbia, V; Testa, A, 1996)
"Metoclopramide was given at a dosage of 2 mg/kg (H) or 1 mg/kg (M), intravenously, 30 minutes before and 2."2.66[Randomized controlled study of high-dose metoclopramide (2 mg/kg x 4:H) vs moderate-dose metoclopramide (1 mg/kg x 4:M) in the prevention of CDDP-induced emesis]. ( Dozono, H; Ohmi, K, 1986)
"and metoclopramide 0."1.29Treatment of cisplatin-related nausea and vomiting with a combination of ondansetron and metoclopramide: a pilot study. ( Cannata, G; Gebbia, N; Gebbia, V; Testa, A, 1996)

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19902 (33.33)18.7374
1990's4 (66.67)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gebbia, V1
Testa, A1
Cannata, G1
Gebbia, N1
Sawaguchi, K1
Yabushita, H1
Tsukada, H1
Yamada, H1
Noguchi, M1
Nakanishi, M1
Singtripop, T1
Mori, T1
Park, MK1
Sakamoto, S1
Kawashima, S1
Vaughn, CB1
Chapman, JL1
Herschman, BR1
Bonczak, MJ1
Treisman, EJ1
Groshko, GA1
Nirenberg, PL1
Chen, JT1
Hirai, Y1
Yagi, H1
Katase, K1
Shimizu, Y1
Nakayama, K1
Teshima, H1
Hamada, T1
Fujimoto, I1
Yamuchi, K1
Dozono, H1
Ohmi, K1

Trials

3 trials available for metoclopramide and Uterine Neoplasms

ArticleYear
[Clinical studies of oral antiemetic drugs on delayed emesis induced by cancer chemotherapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1999, Volume: 26, Issue:1

    Topics: Administration, Oral; Antiemetics; Antineoplastic Agents; Carboplatin; Cisplatin; Cross-Over Studies

1999
[Effect of medical vagotomy on the CDDP induced nausea and vomiting evaluated by the chemotherapy-vomiting time (CV time)].
    Nihon Sanka Fujinka Gakkai zasshi, 1988, Volume: 40, Issue:9

    Topics: Acetaminophen; Adult; Cisplatin; Female; Humans; Metoclopramide; Middle Aged; Nausea; Ovarian Neopla

1988
[Randomized controlled study of high-dose metoclopramide (2 mg/kg x 4:H) vs moderate-dose metoclopramide (1 mg/kg x 4:M) in the prevention of CDDP-induced emesis].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1986, Volume: 13, Issue:3 Pt 1

    Topics: Aged; Cisplatin; Drug Administration Schedule; Female; Humans; Metoclopramide; Middle Aged; Nausea;

1986

Other Studies

3 other studies available for metoclopramide and Uterine Neoplasms

ArticleYear
Treatment of cisplatin-related nausea and vomiting with a combination of ondansetron and metoclopramide: a pilot study.
    Anti-cancer drugs, 1996, Volume: 7, Issue:7

    Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Cisplatin; Cyclophosphamide; Epirubicin; Female; Hu

1996
Development of uterine adenomyosis after treatment with dopamine antagonists in mice.
    Life sciences, 1991, Volume: 49, Issue:3

    Topics: Animals; Corpus Luteum; Dopamine Antagonists; Endometriosis; Estrus; Female; Metoclopramide; Mice; P

1991
Intraperitoneal and systemic chemotherapy for advanced endometrial adenocarcinoma: a case report.
    Medical and pediatric oncology, 1990, Volume: 18, Issue:1

    Topics: Adenocarcinoma; Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplati

1990